Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Format: Artykuł
Język:English
Wydane: Taylor & Francis Group 2019-06-01
Seria:CNS Oncology
Hasła przedmiotowe:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
Dostęp online:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Internet

https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Podobne zapisy